Your search
Results 30 resources
-
Heart failure (HF) is a frequent cause of inpatient admissions. The Framingham study in 1993 described the risk factors for heart failure and showed unacceptably high five-year mortality rates of 25% in men and 38% in women . The American Heart Association reported the prevalence of HF to be 5.1 million in the United States in 2006 . The worldwide prevalence has been estimated to be 23 million . HF can be categorized based on the left ventricular ejection fraction (LVEF) into systolic and...
-
Infection is the leading cause of morbidity and mortality in patients with left ventricular assist devices (LVADs). Prolonged suppressive therapy should be strongly considered and is often utilized in patients with recurrent infections when source control cannot be achieved. Dalbavancin is a promising option in VAD patients requiring prolonged durations of antibiotic therapy, especially when no oral alternatives are available.This case series included eight patients receiving dalbavancin for...
-
BACKGROUND: Cardiovascular disease remains the leading cause of mortality in human im munodeficiency virus-infected (HIV-positive) patients. Ventricular assist device therapy is rarely of fered to these patients and data on outcomes are sparse. We investigated outcomes following ventricular assist device implants for HIV-positive as compared to non-HIV-infected (HIV-negative) patients. METHODS: We analyzed 22,065 patients from the Interagency Registry for Mechanically Assisted Circulatory...
-
Background: Although infections are a significant potential complication among patients undergoing left ventricular assist device (LVAD) implantation, standardized surgical infection prophylaxis (SIP) regimens are not well defined. At Montefiore Medical Center, a 4-drug SIP regimen containing fluconazole, ciprofloxacin, rifampin, and vancomycin was previously utilized. In January 2020, the antimicrobial stewardship program implemented a 2-drug SIP regimen of vancomycin and cefazolin to limit...
-
Infection is a major complication during circulatory support with a left ventricular assist device (VAD). Changes in device characteristics and treatment practices in the last decade can affect the epidemiology of infection. The International Society for Heart and Lung Transplantation (ISHLT) has published recommendations on the prevention and management of VAD infections, but data to support these recommendations remain sparse.We performed a retrospective review of 455 patients who...
-
We review different types of mechanical circulatory support devices available as a bridge to heart transplantation and then discuss infectious complications in these devices, with a particular focus on ventricular assist devices. We also discuss infection prevention and management strategies, in particular as relevent to transplantation.
-
Our institution employs gallium-67 single-photon emission computed tomography low-dose CT (Ga-SPECT-CT) to determine the presence and extent of left ventricular assist device (LVAD) infections. We present a retrospective single-center study of 41 LVAD recipients who underwent Ga-SPECT-CT from January 2011 to June 2018 to determine whether Ga-SPECT-CT led to changes in antimicrobial therapy, LVAD revision or exchange, or application for 1A exception. The average age was 56.6 years,...
-
Background Percutaneous driveline infection is a major complication of left ventricular assist device (LVAD). This study evaluated the role of gallium-67 single-photon emission computed tomography (Ga-SPECT)-CT in LVAD-specific percutaneous driveline infection. Methods Thirty-six patients with implantable continuous-flow LVAD, who underwent Ga-SPECT-CT to evaluate percutaneous driveline infections, were enrolled and divided into uptake and no-uptake groups based on tracer concentration...
-
The usage of left-ventricular-assist device (LVAD) is increasing in patients presenting with advanced heart failure. However, device-related infections are a challenge to recognize and to treat, with an important morbidity and mortality rate. The role of nuclear medicine imaging remains not well established for LVAD infections. The present study compared the accuracy of positron emission tomography/computed tomography with 18F-fludeoxyglucose (18F-FDG PET/CT) and radiolabeled leucocyte...
-
The Infectious Diseases Community of Practice of the American Society of Transplantation has published evidenced-based guidelines on the prevention and management of infectious complications in SOT recipients since 2004. This updated guideline reviews the epidemiology of ventricular assist device (VAD) infections and provides recommendations for the management and prevention of these infections. Almost one half of those awaiting heart transplantation are supported with VADs. Despite advances...
-
Left ventricular assist devices (LVADs) have become a standard treatment modality for the management of end-stage heart failure, either as a bridge to cardiac transplantation or as destination therapy. Infection is a frequent complication in up to one-third of LVAD recipients. Although the epidemiology of LVAD infections has been well-described, strategies for prevention, diagnosis, and management of these infectious complications remain controversial and vary among institutions. The...
-
<h2>Abstract</h2><h3>Objectives</h3><p>The implantable left ventricular assist device (LVAD) is a major therapeutic development for end-stage heart failure in selected patients. As their use is expanding, infectious complications are emerging, with limited data available to guide their management. We aimed to better characterize LVAD-related infections.</p><h3>Methods</h3><p>We enrolled all consecutive patients diagnosed with LVAD-related infections in three referral centres in France, using...
-
BACKGROUND: Infections are major complications in patients with ventricular assist devices (VAD). Positron emission tomography with deoxyglucose marked by fluorine-18 (18F-FDG PET/CT) is a diagnostic tool to scan for tissue with high metabolism as present in infections. The specificity of 18F-FDG PET/CT to discriminate between infection and an aseptic reaction of the implanted device is not defined and its evaluation is the aim of this retrospective analysis.METHODS: Until September 2015 a...
Filter by our tag
GUIDELINES
- AST Guidelines 2019 (1)
- ISHLT Guidelines (4)
TEXTBOOKS
CORE CURRICULUM
ORGANISMS
- BACTERIA (1)
-
FUNGI
(1)
- Aspergillus (1)
- Candida (1)
- Cryptococcus (1)
-
VIRUSES
(2)
- Hepatitis C (1)
- HIV (1)
DIAGNOSTICS
- Nuclear Medicine (5)
DRUGS AND THERAPIES
- Stewardship (1)